𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophilia

✍ Scribed by Köhler, M. ;Hellstern, P. ;Reiter, B. ;Blohn, G. ;Wenzel, E.


Publisher
Springer-Verlag
Year
1984
Tongue
English
Weight
703 KB
Volume
62
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Use of 1-desamino-8-D-arginine vasopress
✍ Suhail K. Mithani; Jared M. Davis; Eduardo D. Rodriguez 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

## Abstract A 19‐year‐old male patient with type 1 von Willebrand's disease underwent two separate superficial inferior epigastric artery free flap tissue transfers and three revision procedures for reconstruction of a postextirpative mid‐facial defect. Intravenous 1‐desamino‐8‐D‐arginine vasopress

1-desamino-8-arginine-vasopressin correc
✍ McKeown, L.P.; Connaghan, G.; Wilson, O.; Hansmann, K.; Merryman, P.; Gralnick, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

DDAVP is effective treatment in most types of von Willebrand's disease; however, in type 28 von Willebrand's disease the use of DDAVP has been contraindicated due to DDAVPinduced thrombocytopenla. Several reports have confirmed the thrombocytopenic effects of DDAVP and the presence of circulating pl